Monday - November 16, 2026
Weight loss alone does not explain lower heart disease for those on semaglutide
September 24, 2026
SOPHIA ANTIPOLIS, France, Sept. 24 [Category: Medical] -- The European Society of Cardiology posted the following news release:

* * *

Weight loss alone does not explain lower heart disease for those on semaglutide

*

Key takeaways:

* The SELECT trial has already shown a 20% lower risk of heart disease for people with overweight or obesity treated with semaglutide.

* New analysis of the trial suggests this cannot be fu . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products